Related references
Note: Only part of the references are listed.Multiple gene expression in plants using MIDAS-P, a versatile type II restriction-based modular expression vector
Elizabeth C. Pinneh et al.
BIOTECHNOLOGY AND BIOENGINEERING (2022)
Engineering the N-glycosylation pathway of Nicotiana tabacum for molecular pharming using CRISPR/Cas9
Kathrin Goritzer et al.
FRONTIERS IN PLANT SCIENCE (2022)
Plant-made dengue virus-like particles produced by co-expression of structural and non-structural proteins induce a humoral immune response in mice
Daniel Ponndorf et al.
PLANT BIOTECHNOLOGY JOURNAL (2021)
On the verge of the market - Plant factories for the automated and standardized production of biopharmaceuticals
J. W. Huebbers et al.
BIOTECHNOLOGY ADVANCES (2021)
A combined pH and temperature precipitation step facilitates the purification of tobacco-derived recombinant proteins that are sensitive to extremes of either parameter
Patrick Opdensteinen et al.
BIOTECHNOLOGY JOURNAL (2021)
Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli, expressed as secretory IgA1 and IgA2 in plants
Audrey Y-H Teh et al.
GUT MICROBES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Fc gamma RIIB is a T cell checkpoint in antitumor immunity
Clara R. Farley et al.
JCI INSIGHT (2021)
Cost-Benefit Analysis of Monoclonal Antibody Cultivation Scenarios in Terms of Life Cycle Environmental Impact and Operating Cost
Eri Amasawa et al.
ACS SUSTAINABLE CHEMISTRY & ENGINEERING (2021)
Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward et al.
NATURE MEDICINE (2021)
Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System
Tanapati Phakham et al.
FRONTIERS IN PLANT SCIENCE (2021)
Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: A systematic review
Xiaoting Ma et al.
JOURNAL OF CANCER (2021)
Engineering the interactions between a plant-produced HIV antibody and human Fc receptors
Szymon Stelter et al.
PLANT BIOTECHNOLOGY JOURNAL (2020)
Molecular farming - The slope of enlightenment
Rainer Fischer et al.
BIOTECHNOLOGY ADVANCES (2020)
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Alireza Labani-Motlagh et al.
FRONTIERS IN IMMUNOLOGY (2020)
Phase I studies of Sym021, an anti-PD-1 antibody, alone and in combination with Sym022 (anti-LAG-3) or Sym023 (anti-TIM-3)
N. Lakhani et al.
ANNALS OF ONCOLOGY (2020)
What CHO is made of: Variations in the biomass composition of Chinese hamster ovary cell lines
Diana Szeliova et al.
METABOLIC ENGINEERING (2020)
Revisiting the PD-1 pathway
Nikolaos Patsoukis et al.
SCIENCE ADVANCES (2020)
Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer
Rilan Bai et al.
FRONTIERS IN ONCOLOGY (2020)
CRISPR/Cas9-mediated knockout of six glycosyltransferase genes in Nicotiana benthamiana for the production of recombinant proteins lacking β-1,2-xylose and core α-1,3-fucose
Julia Jansing et al.
PLANT BIOTECHNOLOGY JOURNAL (2019)
Comparison between Batch and Continuous Monoclonal Antibody Production and Economic Analysis
Ou Yang et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2019)
Comparison of microbial and transient expression (tobacco plants and plant-cell packs) for the production and purification of the anticancer mistletoe lectin viscumin
Benjamin B. Gengenbach et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Takahiro Kamiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
CA224-060: A randomized, open label, phase II trial of relatlimab (anti-LAG-3) and nivolumab with chemotherapy versus nivolumab with chemotherapy as first-line treatment in patients with gastric or gastroesophageal junction adenocarcinoma.
Kynan Feeney et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A simplified techno-economic model for the molecular pharming of antibodies
Pere Mir-Artigues et al.
BIOTECHNOLOGY AND BIOENGINEERING (2019)
Monalizumab: inhibiting the novel immune checkpoint NKG2A
Thorbald van Hall et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
FcγR-Binding Is an Important Functional Attribute for Immune Checkpoint Antibodies in Cancer Immunotherapy
Xin Chen et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Combined Ultrafiltration/Diafiltration Step Facilitates the Purification of Cyanovirin-N From Transgenic Tobacco Extracts
Patrick Opdensteinen et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
Duaa O. Khair et al.
FRONTIERS IN IMMUNOLOGY (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease
Ari Zimran et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy
Tsukasa Seya et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
1302TiPCA224-047: A randomized, double-blind, phase II/III study of relatlimab (anti–LAG-3) in combination with nivolumab (anti–PD-1) versus nivolumab alone in previously untreated metastatic or unresectable melanoma
E J Lipson et al.
ANNALS OF ONCOLOGY (2018)
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
Nadine van Montfoort et al.
CELL (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
[Anonymous]
NATURE REVIEWS DRUG DISCOVERY (2018)
A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors
Vivek Verma et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Technoeconomic Modeling of Plant-Based Griffithsin Manufacturing
Aatif Alam et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2018)
Advanced Plant-Based Glycan Engineering
Laura Montero-Morales et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2018)
Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms
Claudia A. Castro Jaramillo et al.
MABS (2017)
Animal component-free Agrobacterium tumefaciens cultivation media for better GMP-compliance increases biomass yield and pharmaceutical protein expression in Nicotiana benthamiana
Marcel Houdelet et al.
BIOTECHNOLOGY JOURNAL (2017)
Inactivation of the β(1,2)-xylosyltransferase and the α(1,3)-fucosyltransferase genes in Nicotiana tabacum BY-2 Cells by a Multiplex CRISPR/Cas9 Strategy Results in Glycoproteins without Plant-Specific Glycans
Sebastien Mercx et al.
FRONTIERS IN PLANT SCIENCE (2017)
Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti-PD-1/PD-L1 therapy.
Paolo Antonio Ascierto et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Overcoming low yields of plant-made antibodies by a protein engineering approach
Julia Zischewski et al.
BIOTECHNOLOGY JOURNAL (2016)
Global Cancer Incidence and Mortality Rates and Trends-An Update
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Overcoming low yields of plant-made antibodies by a protein engineering approach
Julia Zischewski et al.
BIOTECHNOLOGY JOURNAL (2016)
A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults
Stephan Pillet et al.
CLINICAL IMMUNOLOGY (2016)
Implications of plant glycans in the development of innovative vaccines
Sergio Rosales-Mendoza et al.
EXPERT REVIEW OF VACCINES (2016)
Techno-economic analysis of a transient plant-based platform for monoclonal antibody production
Somen Nandi et al.
MABS (2016)
Plant specific N-glycans do not have proven adverse effects in humans
Yoseph Shaaltiel et al.
NATURE BIOTECHNOLOGY (2016)
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
Richard T. Davey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Engineering of complex protein sialylation in plants
Somanath Kallolimath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions
Tilman Schlothauer et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2016)
A Single-use Strategy to Enable Manufacturing of Affordable Biologics
Renaud Jacquemart et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2016)
The S228P Mutation Prevents in Vivo and in Vitro IgG4 Fab-arm Exchange as Demonstrated using a Combination of Novel Quantitative Immunoassays and Physiological Matrix Preparation
John-Paul Silva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Overall Survival and Long-Term Safety of Nivolumab (Anti-Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
Scott N. Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
Jeffrey S. Weber et al.
LANCET ONCOLOGY (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants
Julian K-C. Ma et al.
PLANT BIOTECHNOLOGY JOURNAL (2015)
Characterization of plants expressing the human β1,4-galactosyltrasferase gene
Jeannine Schneider et al.
PLANT PHYSIOLOGY AND BIOCHEMISTRY (2015)
A juice extractor can simplify the downstream processing of plant-derived biopharmaceutical proteins compared to blade-based homogenizers
J. F. Buyel et al.
PROCESS BIOCHEMISTRY (2015)
Upregulation of PD-LI and APEI is associated with tumorigenesis and poor prognosis of gastric cancer
Yi Qing et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Depth Filters Containing Diatomite Achieve More Efficient Particle Retention than Filters Solely Containing Cellulose Fibers
Johannes F. Buyel et al.
FRONTIERS IN PLANT SCIENCE (2015)
Scale- down models to optimize a filter train for the downstream purification of recombinant pharmaceutical proteins produced in tobacco leaves
Johannes F. Buyel et al.
BIOTECHNOLOGY JOURNAL (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer
Jingying Hou et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
Craig J. van Dolleweerd et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco
Audrey Y-H. Teh et al.
PLANT BIOTECHNOLOGY JOURNAL (2014)
Target Product Selection - Where Can Molecular Pharming Make the Difference?
Mathew J. Paul et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells
Sheng-Jia Shi et al.
PLOS ONE (2013)
Predictive models for transient protein expression in tobacco (Nicotiana tabacum L.) can optimize process time, yield, and downstream costs
J. F. Buyel et al.
BIOTECHNOLOGY AND BIOENGINEERING (2012)
The weight of nations: an estimation of adult human biomass
Sarah Catherine Walpole et al.
BMC PUBLIC HEALTH (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
Chuan-Yong Mu et al.
MEDICAL ONCOLOGY (2011)
Silencing beta 1,2-xylosyltransferase in transgenic tomato fruits reveals xylose as constitutive component of IgE-binding epitopes
Kathrin Elisabeth Paulus et al.
FRONTIERS IN PLANT SCIENCE (2011)
Human Leukocyte Antigen E Contributes to Protect Tumor Cells from Lysis by Natural Killer Cells
Elisa Lo Monaco et al.
NEOPLASIA (2011)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits
Chunsheng Jin et al.
GLYCOBIOLOGY (2008)
Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function
Quin Zhou et al.
BIOTECHNOLOGY AND BIOENGINEERING (2008)
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease
Stefka B. Petkova et al.
INTERNATIONAL IMMUNOLOGY (2006)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Individualized human scFv vaccines produced in plants:: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig
AA McCormick et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Immunoreactivity in mammals of two typical plant glyco-epitopes, core α(1,3)-fucose and core xylose
M Bardor et al.
GLYCOBIOLOGY (2003)
被撤回的出版物: An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus (Retracted article. See vol. 84, pg. 846, 2015)
O Voinnet et al.
PLANT JOURNAL (2003)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Share Paper
